Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
British Journal of Pharmacology
|
July 30, 2015
Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate
E Peters, S Geraci, S Heemskerk, et al.
The Netherlands Journal of Medicine
|
October 21, 2009
Internal medicine residents' knowledge about sepsis: effects of a teaching intervention
M Tromp, C P Bleeker-Rovers, T van Achterberg, et al.
British Journal of Anaesthesia
|
December 22, 2011
Dynamic indices do not predict volume responsiveness in routine clinical practice
B Lansdorp, J Lemson, M J A M van Putten, et al.
Journal of Breath Research
|
July 23, 2013
Pulmonary infection, and not systemic inflammation, accounts for increased concentrations of exhaled nitric oxide in patients with septic shock
J ten Oever, J Mandon, M G Netea, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients
E J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Brain, Behavior, and Immunity
|
May 10, 2024
Corrigendum to "Systemic inflammation relates to neuroaxonal damage associated with long-term cognitive dysfunction in COVID-19 patients" [Brain Behav. Immun. 117 (2024) 510-520]
H B Duindam, D Mengel, M Kox, et al.
The Netherlands Journal of Medicine
|
September 16, 2004
Hypothesis: Normalisation of cytokine dysbalance explains the favourable effects of strict glucose regulation in the critically ill
P Pickkers, A Hoedemaekers, M G Netea, et al.
Clinical Science (London, England : 1979)
|
March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes
E J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Brain, Behavior, and Immunity
|
February 9, 2024
Systemic inflammation relates to neuroaxonal damage associated with long-term cognitive dysfunction in COVID-19 patients
H B Duindam, D Mengel, M Kox, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2016
Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal Infections
R J M Brüggemann, V Middel-Baars, D W de Lange, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
British Journal of Pharmacology
|
July 30, 2015
Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate
E Peters, S Geraci, S Heemskerk, et al.
The Netherlands Journal of Medicine
|
October 21, 2009
Internal medicine residents' knowledge about sepsis: effects of a teaching intervention
M Tromp, C P Bleeker-Rovers, T van Achterberg, et al.
British Journal of Anaesthesia
|
December 22, 2011
Dynamic indices do not predict volume responsiveness in routine clinical practice
B Lansdorp, J Lemson, M J A M van Putten, et al.
Journal of Breath Research
|
July 23, 2013
Pulmonary infection, and not systemic inflammation, accounts for increased concentrations of exhaled nitric oxide in patients with septic shock
J ten Oever, J Mandon, M G Netea, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients
E J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Brain, Behavior, and Immunity
|
May 10, 2024
Corrigendum to "Systemic inflammation relates to neuroaxonal damage associated with long-term cognitive dysfunction in COVID-19 patients" [Brain Behav. Immun. 117 (2024) 510-520]
H B Duindam, D Mengel, M Kox, et al.
The Netherlands Journal of Medicine
|
September 16, 2004
Hypothesis: Normalisation of cytokine dysbalance explains the favourable effects of strict glucose regulation in the critically ill
P Pickkers, A Hoedemaekers, M G Netea, et al.
Clinical Science (London, England : 1979)
|
March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes
E J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Brain, Behavior, and Immunity
|
February 9, 2024
Systemic inflammation relates to neuroaxonal damage associated with long-term cognitive dysfunction in COVID-19 patients
H B Duindam, D Mengel, M Kox, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2016
Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal Infections
R J M Brüggemann, V Middel-Baars, D W de Lange, et al.
Page
of 8